The importance of high-quality clinical research is obvious. The Swiss Group for Clinical Cancer Research (SAKK) plays an important role in Swiss cancer research. One quality feature is the publication rate - 95.8 % of the research projects carried out with the participation of SAKK are published, as recently published data in the BMJ show.

In this interview, Stefanie Hayoz, head of SAKK's statistics team, dives into the statistics and explains the background and significance of this data for clinical cancer research.